Ceibo Health Consulting

Public health is a pressing issue in Brazil, which boasts a population exceeding 211 million. This large demographic faces a growing health burden, with health expenditures accounting for approximately 4.5% of the country's GDP in 2021. The majority of this spending focuses on public health initiatives. For more details, read here: https://lnkd.in/dhY2AP4k Engaging with public healthcare stakeholders and government agencies is essential for companies looking to enter the Brazilian healthcare market successfully. Together with our local partners, we possess the connections, expertise, and resources to assist your medical company with market access research and strategy, ensuring that your products and services can effectively reach the Brazilian market.

I founded Ceibo Health two years ago, and named it after Argentina's national flower, where I dedicated fifteen years to working in the pharmaceutical industry and almost 7 as an independent consultant. My local connection to Argentina and the LATAM region makes us different at Ceibo Health. We specialize in market access, health economics, and pipeline development for healthcare companies throughout the LATAM region. We leverage locally based partners and connections with regional healthcare stakeholders, enabling us to manage projects across multiple countries. To learn more about our services, reach out to us today.

In 2021, several LATAM countries reported alarmingly high pneumonia death rates, including Guatemala (63.7/100,000), Peru (60.1/100,000), Bolivia (60.2/100,000), and Argentina (52.3/100,000) (Our World in Data). Expanding access to healthcare infrastructure and vaccines for respiratory illnesses could significantly reduce these numbers and improve survival outcomes. As market access consultants, we specialize in connecting companies with policymakers and healthcare stakeholders to bring life-saving products, like pneumonia treatments and vaccines, to those who need them most in these regions. Let’s work together to make a difference. #ceibohealthconsulting, #LATAM, #healtheconomics

Healthcare spending is rising across LATAM, with countries like Mexico and Brazil leading the charge (McKinsey). This trend presents a critical opportunity for global medical technology and device companies to expand market access—but only with the right partners. Our locally based consultant team is perfectly positioned to connect your company with the stakeholders and policymakers you need to bring your products and services to market in the LATAM region. Let’s discuss how we can help your business seize this opportunity. Contact us today for a consultation. #ceibohealthconsulting, #latinamerica, #LATAMbusiness ?

Ceibo Health Consulting specializes in helping bring groundbreaking medical treatments to the LATAM market by providing the critical data and insights needed to navigate regional complexities. Recently, we supported the launch of a CAR-T cell therapy for multiple myeloma in Argentina, delivering a comprehensive study on the treatment landscape, pricing, and market access. Through our locally based partners, we provided essential, region-specific data that guided the development of an effective access strategy for this innovative therapy. If your team plans to introduce a new medical device or treatment in LATAM, we’re here to help ensure your success. #CeiboHealthConsulting #DrugManufacturing #MedicalDevices

Pneumonia remains a serious threat, particularly among vulnerable populations like children. In 2021, Mexico saw a pneumonia death rate of 18.2 per 100,000 people—significantly higher than Argentina's 7.1 per 100,000 (Our World In Data). In regions with limited healthcare access, addressing respiratory illnesses is an urgent concern. That's why we're proud to have supported a paediatric pricing secondary and primary research assessment of a new?pneumococcal vaccine in Argentina and Mexico in 2023. We’re hopeful that this work will help bring life-saving vaccines to the most vulnerable, both in these nations and across the LATAM region. #ceibohealthconsulting, #research, #marketresearch ?

Passion, commitment, hands-on expertise, and a focus on the finer details define who we are at Ceibo Health. In 2022, when I took the significant step of founding Ceibo Health, I had a clear mission: to leverage my consulting skills and industry experience to support healthcare companies in the LATAM region, focusing on market access, research, and strategy with local stakeholders. Our hands-on approach has been vital to delivering exceptional client results. We are proud to have completed over 150 projects across various formats, therapeutic areas, and geographies. Our work focuses on market research insights, value evidence generation, and policy analysis, which have been central to many of our initiatives. Whether transforming market access strategies, conducting budget impact studies, or performing pricing research for new treatments, we are committed to delivering quality and ensuring customer satisfaction—while enjoying the journey along the way! Over the past two years, these remarkable projects and countless others have fueled Ceibo Health’s growth and allowed us to bring much-needed healthcare innovations, resources, and access to the LATAM region. I want to thank my team, partners, and clients for trusting Ceibo Health. As our journey continues, I find inspiration in the words of Brazilian educator Paulo Freire: "The greatest way to make a difference is to be the change you wish to see in the world." I’m proud of the difference we make at Ceibo Health. Happy anniversary! #marketaccess #marketstrategy

Ulcerative colitis (UC) is a chronic inflammatory bowel disease that affects millions. It causes symptoms like abdominal pain, diarrhea, rectal bleeding, and weight loss. The treatment landscape for UC offers various options—anti-inflammatory drugs, immunosuppressants, biologics, and small molecules—designed to manage symptoms, reduce inflammation, and induce remission. Our team is ready to provide region-specific research to support the introduction of new treatments in the LATAM market. In 2022, we conducted comprehensive secondary and primary research on pricing and market access targeting Crohn’s Disease and Ulcerative Colitis in Argentina. With the prevalence of UC rising in the LATAM region, there is an increasing emphasis on research and development to discover more effective and safer therapies. Learn more about the UC treatment market here: https://lnkd.in/d_KmNSAh #ceibohealthconsulting, #research #consultingservices

According to ESMO, cancer is the leading cause of premature death in nearly half of all Latin American countries, and the cancer burden is expected to rise in the coming decades. With new treatments and drugs urgently needed, improving market access is more critical than ever. Learn more: https://lnkd.in/dwemu4Sm Our team of locally based partner consultants specializes in LATAM market entry, leveraging extensive experience to streamline access to innovative cancer treatments. Recently, we supported a global company in conducting primary and secondary market research for a new drug targeting osteosarcoma, one for multiple myeloma, one for breast cancer and one for NSCLC. Thanks to our expertise, these breakthrough treatments will reach patients in LATAM markets faster, offering hope for more effective cancer care. If your company needs market access support in the region, let’s connect. We’re here to help. https://lnkd.in/dJQMRbz6

At Ceibo Health Consulting, we know that bringing your data to the right stakeholders is critical to the success of your medical products and devices. We specialize in developing tailored evidence-generation strategies that demonstrate your innovations' economic and medical value to policymakers, healthcare providers, and government agencies across the LATAM region. With our expertise, you’ll be equipped to navigate the market and effectively showcase the impact of your products. #ceibohealthconsulting #healtheconomics #medtech